Stamps et al., 2013 - Google Patents
A brief olfactory test for Alzheimer's diseaseStamps et al., 2013
View HTML- Document ID
- 13470790720710132625
- Author
- Stamps J
- Bartoshuk L
- Heilman K
- Publication year
- Publication venue
- Journal of the neurological sciences
External Links
Snippet
Background The early diagnosis of Alzheimer's disease (AD) may help reduce disability, enhance quality of life, and aid clinical trials. Portions of olfactory cortex are the initial sites of AD pathology and patients with AD often have more degeneration of their left than right …
- 206010001897 Alzheimer's disease 0 title abstract description 115
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/40—Detecting, measuring or recording for evaluating the nervous system
- A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system
- A61B5/4088—Diagnosing of monitoring cognitive diseases, e.g. Alzheimer, prion diseases or dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/16—Devices for psychotechnics; Testing reaction times; Devices for evaluating the psychological state
- A61B5/165—Evaluating the state of mind, e.g. depression, anxiety
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stamps et al. | A brief olfactory test for Alzheimer's disease | |
| Jung et al. | Olfactory function in mild cognitive impairment and Alzheimer's disease: A meta‐analysis | |
| Brenowitz et al. | Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic-and community-based samples | |
| Schmid et al. | The extension of the German CERAD neuropsychological assessment battery with tests assessing subcortical, executive and frontal functions improves accuracy in dementia diagnosis | |
| Knopman et al. | Practice parameter: Diagnosis of dementia (an evidence-based review) Report of the Quality Standards Subcommittee of the American Academy of Neurology | |
| Chertkow et al. | Mild cognitive impairment and cognitive impairment, no dementia: Part A, concept and diagnosis | |
| Knopman | The initial recognition and diagnosis of dementia | |
| Traykov et al. | Patterns of memory impairment and perseverative behavior discriminate early Alzheimer's disease from subcortical vascular dementia | |
| Bottiggi et al. | The HIV Dementia Scale: predictive power in mild dementia and HAART | |
| Potvin et al. | State anxiety and cognitive functioning in older adults | |
| Salimi et al. | Visuospatial dysfunction in Alzheimer's disease and behavioural variant frontotemporal dementia | |
| Nielsen et al. | Quality of dementia diagnostic evaluation for ethnic minority patients: a nationwide study | |
| Devier et al. | The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease | |
| Samarasekera et al. | Cognitive impairment in adults with epilepsy: the relationship between subjective and objective assessments of cognition | |
| Sanz et al. | Anosognosia in Alzheimer disease: Prevalence, associated factors, and influence on disease progression | |
| Abrahams | Neuropsychological impairment in amyotrophic lateral sclerosis–frontotemporal spectrum disorder | |
| Russo et al. | Usefulness of discriminability and response bias indices for the evaluation of recognition memory in mild cognitive impairment and Alzheimer disease | |
| Parrao et al. | The Structured Interview for Insight and Judgment in Dementia: Development and validation of a new instrument to assess awareness in patients with dementia | |
| Shabani et al. | The Persian Bipolar Spectrum Diagnostic Scale and mood disorder questionnaire in screening the patients with bipolar disorder | |
| Janelidze et al. | Mild cognitive impairment | |
| Firbank et al. | Hippocampal and insula volume in mild cognitive impairment with Lewy bodies | |
| Cosentino et al. | Does essential tremor increase risk of cognitive impairment and dementia? Yes | |
| Afshar et al. | Reliability and validity of a quick test of cognitive speed (AQT) in screening for mild cognitive impairment and dementia | |
| Miebach et al. | Different cognitive complaint profiles in memory clinic and depressive patients | |
| Song et al. | Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia |